Target
Dual specificity protein kinase TTK
Ligand
BDBM50053316
Substrate
n/a
Meas. Tech.
ChEMBL_1458488 (CHEMBL3370374)
IC50
1400±n/a nM
Citation
 Laufer, RNg, GLiu, YPatel, NKEdwards, LGLang, YLi, SWFeher, MAwrey, DELeung, GBeletskaya, IPlotnikova, OMason, JMHodgson, RWei, XMao, GLuo, XHuang, PGreen, EKiarash, RLin, DCHarris-Brandts, MBan, FNadeem, VMak, TWPan, GJQiu, WChirgadze, NYPauls, HW Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. Bioorg Med Chem 22:4968-97 (2014) [PubMed]  Article 
Target
Name:
Dual specificity protein kinase TTK
Synonyms:
Dual specificity protein kinase (TTK) | Dual specificity protein kinase TTK (MPS1) | MPS1 | MPS1L1 | Monopolar Spindle 1 (MPS1) | Monopolar Spindle 1 (Mps-1) | Monopolar Spindle 1 Kinase (MPS1) | Phosphotyrosine picked threonine-protein kinase (MPS1) | TTK | TTK_HUMAN
Type:
Protein
Mol. Mass.:
97086.79
Organism:
Homo sapiens (Human)
Description:
P33981
Residue:
857
Sequence:
MESEDLSGRELTIDSIMNKVRDIKNKFKNEDLTDELSLNKISADTTDNSGTVNQIMMMANNPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLTAQESFSGSLGHLQNRNNSCDSRGQTTKARFLYGENMPPQDAEIGYRNSLRQTNKTKQSCPFGRVPVNLLNSPDCDVKTDDSVVPCFMKRQTSRSECRDLVVPGSKPSGNDSCELRNLKSVQNSHFKEPLVSDEKSSELIITDSITLKNKTESSLLAKLEETKEYQEPEVPESNQKQWQSKRKSECINQNPAASSNHWQIPELARKVNTEQKHTTFEQPVFSVSKQSPPISTSKWFDPKSICKTPSSNTLDDYMSCFRTPVVKNDFPPACQLSTPYGQPACFQQQQHQILATPLQNLQVLASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK
  
Inhibitor
Name:
BDBM50053316
Synonyms:
CHEMBL3330243
Type:
Small organic molecule
Emp. Form.:
C19H13F2N3O2S
Mol. Mass.:
385.387
SMILES:
NS(=O)(=O)c1cccc(c1)-c1n[nH]c2cccc(-c3c(F)cccc3F)c12 |(19.97,-9.17,;19.18,-7.85,;20.51,-7.06,;19.17,-6.31,;17.64,-7.87,;16.86,-6.54,;15.31,-6.57,;14.56,-7.91,;15.35,-9.22,;16.89,-9.21,;14.6,-10.57,;15.51,-11.82,;14.6,-13.08,;13.12,-12.6,;11.79,-13.37,;10.46,-12.6,;10.46,-11.05,;11.79,-10.28,;11.78,-8.74,;10.45,-7.99,;9.12,-8.77,;10.44,-6.45,;11.77,-5.67,;13.11,-6.44,;13.11,-7.97,;14.45,-8.74,;13.12,-11.05,)|
Structure:
Search PDB for entries with ligand similarity: